Governance

Strategic Advisory Board


The Strategic Advisory Board (SAB) is composed of international leaders in the fields of genomics research, medicine, and patient advocacy, and includes representatives from GA4GH host institutions and major funding bodies. The SAB provides high-level guidance and insight on areas of strategic growth and guides our direction as a thought leader on clinical and genomic data sharing.

Charles Sawyers
Charles Sawyers

Memorial Sloan Kettering Cancer Center
New York, United States

Member, Strategic Advisory Board

David Altshuler
David Altshuler

Vertex Pharmaceuticals
Boston, United States

Member, Strategic Advisory Board

Eric Lander
Eric Lander

Broad Institute
Cambridge, United States

Member, Strategic Advisory Board

Francis Collins
Francis Collins

National Institutes of Health
Bethesda, United States

Member, Strategic Advisory Board

Harold Varmus
Harold Varmus

Weill Cornell Medicine
New York City, United States

Chair, Strategic Advisory Board

Jeremy Farrar
Jeremy Farrar

Wellcome
London, United Kingdom

Member, Strategic Advisory Board

Michael Stratton
Michael Stratton

Wellcome Sanger Institute
Hinxton, United Kingdom

Member, Strategic Advisory Board

Sharon Terry
Sharon Terry

Genetic Alliance
Washington D.C., United States

Member, Regulatory and Ethics Work Stream Member, Strategic Advisory Board

Susan Desmond-Hellmann
Susan Desmond-Hellmann

Bill & Melinda Gates Foundation
Seattle, United States

Member, Strategic Advisory Board

Thomas Hudson
Thomas Hudson

AbbVie
Redwood City, United States

Member, Strategic Advisory Board